Cytek Biosciences Inc (CTKB) Stock Price, Quote & News

Company Profile

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. The company offers aurora and northern lights systems delivers cell analysis; aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; enhanced small particle detection; amnis imagestream imaging flow cytometers; guava muse cell analyzers; g...

Industry: Medical Devices

Sector: Healthcare

Phone: 877 922 9835

Website: cytekbio.com

Address:

47215 Lakeview Boulevard, Fremont, United States

SigilShares Dec. 25 at 12:30 PM

$CTKB Market behavior suggests investors are rewarding credible delivery more than theoretical upside. Commercial adoption must become steadier to neutralize skepticism around sustainability. If milestones arrive on time, perception can shift faster than fundamentals. Catalysts help, but operating proof ultimately carries the most weight.

0 · Reply

fjtbnh Dec. 18 at 5:39 AM

$CTKB

0 · Reply

SuperGreenToday Dec. 5 at 2:44 PM

$CTKB Share Price: $5.14 Contract Selected: Jul 17, 2026 $5 Calls Buy Zone: $1.95 – $2.41 Target Zone: $3.71 – $4.54 Potential Upside: 80% ROI Time to Expiration: 223 Days | Updates via https://fxcapta.com/stockinfo/

0 · Reply

TylerDurd3n Nov. 30 at 3:32 AM

$CTKB

0 · Reply

Beepboopscoop Nov. 26 at 2:13 PM

$CTKB People are sleeping on this one.

1 · Reply

GSP Nov. 24 at 1:43 AM

$AMTM $CTKB $DVLT $NNOX $WMT

0 · Reply

KirRoyalTrader Nov. 23 at 9:48 PM

$CTKB

0 · Reply

BioTechHealthX Nov. 18 at 4:05 AM

$CTKB Cytek Biosciences Inc. (CTKB) jumped 39% in just 30 days after being named to TIME’s 2026 America’s Growth Leaders list. With CTKB trading near $5.50 despite industry accolades, rising recurring revenue, and expanding global adoption, investors are asking whether the market is still undervaluing this full-spectrum cytometry powerhouse. https://biotechhealthx.com/biotech-news/cytek-bio-ctkb-surges-39-in-1-month-after-time-2026-recognition/

0 · Reply

TraderJay85 Nov. 17 at 11:34 PM

$APUS $OTLK $SGBX $QNRX $CTKB And many more.... Small losses or huge gains. Come learn how to manage your trades and always take gains.

0 · Reply

Joby099 Nov. 17 at 9:30 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X Great call! LFGGG

0 · Reply

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

Nov 12, 2025, 5:00 PM EST - 6 weeks ago

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

Nov 6, 2025, 5:00 PM EST - 7 weeks ago

Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year

Nov 6, 2025, 4:05 PM EST - 7 weeks ago

Cytek Biosciences to Participate in Upcoming Investor Conferences

Nov 5, 2025, 8:51 PM EST - 7 weeks ago

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:05 PM EST - 7 weeks ago

Cytek Biosciences Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 5:00 PM EDT - 2 months ago

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

Oct 22, 2025, 4:05 PM EDT - 2 months ago

Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025

Oct 15, 2025, 5:00 PM EDT - 2 months ago

Cytek® Biosciences Expands European Presence with New Facility in Amsterdam to Better Serve Customers and Drive Growth

Sep 17, 2025, 9:00 AM EDT - 3 months ago

Cellares Selects Five Best-in-Class Technology Providers, Tecan, Advanced Instruments, Cytek Biosciences, Slingshot Biosciences and AltemisLab, to Expand Cell Q's Capabilities in Meeting Demands for Commercial Scale Cell Therapy Quality Control

Sep 10, 2025, 5:00 PM EDT - 3 months ago

Cytek Biosciences Brings Full Spectrum Cell Analysis to Leading Clinical Global Conferences ICCS and ESCCA

Sep 10, 2025, 12:57 PM EDT - 3 months ago

Cytek Biosciences, Inc. (CTKB) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)

Aug 7, 2025, 4:25 AM EDT - 5 months ago

Cytek Biosciences, Inc. (CTKB) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 4:05 PM EDT - 5 months ago

Cytek Biosciences Reports Second Quarter 2025 Financial Results

May 29, 2025, 5:00 PM EDT - 7 months ago

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

May 28, 2025, 4:05 PM EDT - 7 months ago

Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference

May 11, 2025, 8:30 PM EDT - 8 months ago

Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 8 months ago

Cytek Biosciences Reports First Quarter 2025 Financial Results

May 5, 2025, 8:14 AM EDT - 8 months ago

Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued?

Apr 29, 2025, 5:00 PM EDT - 8 months ago

Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025

Apr 28, 2025, 8:15 AM EDT - 8 months ago

Why Cytek Biosciences Should Beat Q1 Earnings Expectations

Apr 24, 2025, 4:05 PM EDT - 8 months ago

Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 18, 2025, 5:00 PM EDT - 10 months ago

Cytek® Biosciences Expands Cell Analysis Offerings with the Affordable, User-Friendly Cytek® Muse® Micro System

Feb 28, 2025, 9:49 AM EST - 10 months ago

Cytek Biosciences, Inc. (CTKB) Q4 2024 Earnings Conference Call Transcript

Feb 27, 2025, 4:05 PM EST - 10 months ago

Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook

Feb 13, 2025, 4:05 PM EST - 11 months ago

Cytek Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

Jan 9, 2025, 9:30 AM EST - 1 year ago

Upgrading Cytek Biosciences Stock On An Upcoming Catalyst

Jan 2, 2025, 8:00 AM EST - 1 year ago

Cytek Biosciences to present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 30, 2024, 8:00 AM EST - 1 year ago

Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025

Nov 20, 2024, 4:05 PM EST - 1 year ago

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 19, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

Nov 7, 2024, 5:00 PM EST - 1 year ago

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

Nov 5, 2024, 8:26 PM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript

Sep 18, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and Europe

Sep 12, 2024, 3:20 PM EDT - 1 year ago

Cytek Announces Resignation of Chief Operating Officer Chris Williams

Aug 21, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility

Aug 11, 2024, 4:25 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q2 2024 Earnings Call Transcript

Jul 30, 2024, 5:00 PM EDT - 1 year ago

Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm

May 30, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare Conference

May 28, 2024, 5:30 PM EDT - 1 year ago

1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in China

May 23, 2024, 9:17 AM EDT - 1 year ago

Lab Instrument Industry Update - New Commercial Entrants

AKYA BNGO DHR LAB MASS OMIC QGEN

May 20, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems

May 12, 2024, 3:24 AM EDT - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q1 2024 Earnings Call Transcript

May 8, 2024, 4:05 PM EDT - 1 year ago

Cytek Biosciences Reports First Quarter 2024 Financial Results

Apr 30, 2024, 5:30 PM EDT - 1 year ago

Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe

Apr 29, 2024, 9:00 AM EDT - 1 year ago

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

Mar 20, 2024, 4:33 AM EDT - 1 year ago

Cytek Biosciences: Undisputed Next-Gen Flow Cytometry Leader

Mar 19, 2024, 8:00 AM EDT - 1 year ago

Cytek® Biosciences Names William McCombe Chief Financial Officer

Mar 7, 2024, 5:30 PM EST - 1 year ago

Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions

Feb 28, 2024, 7:24 PM EST - 1 year ago

Cytek Biosciences, Inc. (CTKB) Q4 2023 Earnings Call Transcript

SigilShares Dec. 25 at 12:30 PM

0 · Reply

fjtbnh Dec. 18 at 5:39 AM

$CTKB

0 · Reply

SuperGreenToday Dec. 5 at 2:44 PM

0 · Reply

TylerDurd3n Nov. 30 at 3:32 AM

$CTKB

0 · Reply

Beepboopscoop Nov. 26 at 2:13 PM

$CTKB People are sleeping on this one.

1 · Reply

GSP Nov. 24 at 1:43 AM

$AMTM $CTKB $DVLT $NNOX $WMT

0 · Reply

KirRoyalTrader Nov. 23 at 9:48 PM

$CTKB

0 · Reply

BioTechHealthX Nov. 18 at 4:05 AM

0 · Reply

TraderJay85 Nov. 17 at 11:34 PM

$APUS $OTLK $SGBX $QNRX $CTKB And many more.... Small losses or huge gains. Come learn how to manage your trades and always take gains.

0 · Reply

Joby099 Nov. 17 at 9:30 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X Great call! LFGGG

0 · Reply

Joby099 Nov. 17 at 12:53 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X

0 · Reply

Manusia1 Nov. 17 at 8:11 AM

$CTKB 312 watchers. why so low?

0 · Reply

jdlman Nov. 17 at 3:58 AM

$CTKB lets have another great week here

0 · Reply

Joby099 Nov. 17 at 1:02 AM

$UVXY $CTKB $ZEC.X $SPY $LTC.X

0 · Reply

SadyK189 Nov. 16 at 11:48 PM

Top Stocks to watch next week 2 / 2: $QNRX $GLTO $TXMD $APUS $CTKB QNRX: Initially alerted for 14.40 - 15.10. It went till 15.46 afterwards. Getting better on 4hours chart. Key support at 11.80 - 12.40. Next key level to test is 15.90 - 16.45. Currently at 14.33 TXMD: Looking good on daily chart. Key support at 1.35 - 1.50. Next key level to test is 2.25 - 2.45. Currently at 1.88 GLTO: Looking good on daily chart. key support at 19 - 21. Next key level to test is 32.50 - 33.95. Currently at 27.62 CTKB: Good close of daily candle. Key support at 4.6 - 4.95. Next key level to test is 6.75 - 7.10. Currently at 5.90 APUS: Looking good on 4hours chart. Key support at 2.40 - 2.65. Next key level to test is 3.7 - 3.95. Currently at 3.21

0 · Reply

Joby099 Nov. 16 at 6:59 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X

0 · Reply

Joby099 Nov. 16 at 2:30 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X

0 · Reply

Joby099 Nov. 15 at 9:29 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X

0 · Reply

avoid Nov. 15 at 8:24 PM

$CTKB https://www.sec.gov/Archives/edgar/data/1061983/000189761225000526/xslSCHEDULE_13G_X01/primary_doc.xml

2 · Reply

GSP Nov. 15 at 8:02 PM

$SPY $PALI $ONDS $CYCU $CTKB

0 · Reply

FonsieTrader Nov. 15 at 4:42 PM

$CTKB — Massive Weekly Shift in Momentum It just delivered a strong weekly close, breaking out of a long multi-month downtrend with conviction. Technical Highlights: • Trendline breakout on high volume — confirms buyers stepping in aggressively. • Price reclaimed the full Keltner channel — a clear signal of trend reversal. • MFI & OBV both rising → accumulation is real and consistent. • ADX turning up — momentum strengthening after a long base. • Weekly structure now points toward a bigger move developing. In As long as it holds above 5.00, this breakout has legs. Next major resistance sits near 9.20 Powerful weekly close → momentum shift → upside unlocked.

0 · Reply

Joby099 Nov. 15 at 3:40 PM

$UVXY $CTKB $ZEC.X $SPY $LTC.X Great pick ! https://www.youtube.com/watch?v=nehVp_RQQx8&t=557s

0 · Reply

Market Cap	652.11M
Revenue (ttm)	200.45M
Net Income (ttm)	-6.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-3.00%
Debt to Equity Ratio	0.00

Volume	479,800
Avg Vol	1,358,526
Day's Range	N/A - N/A
Shares Out	127.87M
Stochastic %K	86%
Beta	1.29
Analysts	Sell
Price Target	$5.75